Loading…

Ru(II) Phenanthroline-Based Oligothienyl Complexes as Phototherapy Agents

Ru­(II) polypyridyl complexes have gained widespread attention as photosensitizers for photodynamic therapy (PDT). Herein, we systematically investigate a series of the type [Ru­(phen)2(IP-nT)]2+, featuring 1,10-phenanthroline (phen) coligands and imidazo­[4,5-f]­[1,10]­phenanthroline ligands tether...

Full description

Saved in:
Bibliographic Details
Published in:Inorganic chemistry 2023-12, Vol.62 (51), p.21181-21200
Main Authors: Cole, Houston D., Vali, Abbas, Roque, John A., Shi, Ge, Kaur, Gurleen, Hodges, Rachel O., Francés-Monerris, Antonio, Alberto, Marta E., Cameron, Colin G., McFarland, Sherri A.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-a407t-a9835a1f6d1506fc22fe883c522f64356951b8a6b264e4ad01ecf66272960ea83
cites cdi_FETCH-LOGICAL-a407t-a9835a1f6d1506fc22fe883c522f64356951b8a6b264e4ad01ecf66272960ea83
container_end_page 21200
container_issue 51
container_start_page 21181
container_title Inorganic chemistry
container_volume 62
creator Cole, Houston D.
Vali, Abbas
Roque, John A.
Shi, Ge
Kaur, Gurleen
Hodges, Rachel O.
Francés-Monerris, Antonio
Alberto, Marta E.
Cameron, Colin G.
McFarland, Sherri A.
description Ru­(II) polypyridyl complexes have gained widespread attention as photosensitizers for photodynamic therapy (PDT). Herein, we systematically investigate a series of the type [Ru­(phen)2(IP-nT)]2+, featuring 1,10-phenanthroline (phen) coligands and imidazo­[4,5-f]­[1,10]­phenanthroline ligands tethered to n = 0–4 thiophene rings (IP-nT). The complexes were characterized and investigated for their electrochemical, spectroscopic, and (photo)­biological properties. The electrochemical oxidation of the nT unit shifted by −350 mV as n = 1 → 4 (+920 mV for Ru-1T, +570 mV for Ru-4T); nT reductions were observed in complexes Ru-3T (−2530 mV) and Ru-4T (−2300 mV). Singlet oxygen quantum yields ranged from 0.53 to 0.88, with Ru-3T and Ru-4T being equally efficient (∼0.88). Time-resolved absorption spectra of Ru-0T–1T were dominated by metal-to-ligand charge-transfer (3MLCT) states (τTA = 0.40–0.85 μs), but long-lived intraligand charge-transfer (3ILCT) states were observed in Ru-2T–4T (τTA = 25–148 μs). The 3ILCT energies of Ru-3T and Ru-4T were computed to be 1.6 and 1.4 eV, respectively. The phototherapeutic efficacy against melanoma cells (SK-MEL-28) under broad-band visible light (400–700 nm) increases as n = 0 → 4: Ru-0T was inactive up to 300 μM, Ru-1T–2T were moderately active (EC50 ∼ 600 nM, PI = 200), and Ru-3T (EC50 = 57 nM, PI > 1100) and Ru-4T (EC50 = 740 pM, PI = 114,000) were the most phototoxic. The activity diminishes with longer wavelengths of light and is completely suppressed for all complexes except Ru-3T and Ru-4T in hypoxia. Ru-4T is the more potent and robust PS in 1% O2 over seven biological replicates (avg EC50 = 1.3 μM, avg PI = 985). Ru-3T exhibited hypoxic activity in five of seven replicates, underscoring the need for biological replicates in compound evaluation. Singlet oxygen sensitization is likely responsible for phototoxic effects of the compounds in normoxia, but the presence of redox-active excited states may facilitate additional photoactive pathways for complexes with three or more thienyl groups. The 3ILCT state with its extended lifetime (30–40× longer than the 3MLCT state for Ru-3T and Ru-4T) implicates its predominant role in photocytotoxicity.
doi_str_mv 10.1021/acs.inorgchem.3c03216
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_2902935402</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2902935402</sourcerecordid><originalsourceid>FETCH-LOGICAL-a407t-a9835a1f6d1506fc22fe883c522f64356951b8a6b264e4ad01ecf66272960ea83</originalsourceid><addsrcrecordid>eNqFkUFrGzEQhUVpqB23P6Fhj-lhnZG00q5OITFNYwgkhBZ6E7I8692wK7nSbqj_fRXsmuSU0wzM994M8wj5SmFOgdELY-O8dT5sbIP9nFvgjMoPZEoFg1xQ-P2RTAFST6VUE3Ia4xMAKF7IT2TCKygVr8opWT6O58vlt-yhQWfc0ATftQ7zaxNxnd137cYPTYtu12UL3287_IsxMzHhfkgTDGa7y6426Ib4mZzUpov45VBn5NfN95-L2_zu_sdycXWXmwLKITeq4sLQWq6pAFlbxmqsKm5FamTBhVSCriojV0wWWJg1ULS1lKxkSgKais_I5d53O656XNu0O5hOb0Pbm7DT3rT67cS1jd74Z02hFAWjKjmcHxyC_zNiHHTfRotdZxz6MWqmgCkuCmAJFXvUBh9jwPq4h4J-yUGnHPQxB33IIenOXh95VP1_fALoHnjRP_kxuPSzd0z_AQQpmVA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2902935402</pqid></control><display><type>article</type><title>Ru(II) Phenanthroline-Based Oligothienyl Complexes as Phototherapy Agents</title><source>American Chemical Society:Jisc Collections:American Chemical Society Read &amp; Publish Agreement 2022-2024 (Reading list)</source><creator>Cole, Houston D. ; Vali, Abbas ; Roque, John A. ; Shi, Ge ; Kaur, Gurleen ; Hodges, Rachel O. ; Francés-Monerris, Antonio ; Alberto, Marta E. ; Cameron, Colin G. ; McFarland, Sherri A.</creator><creatorcontrib>Cole, Houston D. ; Vali, Abbas ; Roque, John A. ; Shi, Ge ; Kaur, Gurleen ; Hodges, Rachel O. ; Francés-Monerris, Antonio ; Alberto, Marta E. ; Cameron, Colin G. ; McFarland, Sherri A.</creatorcontrib><description>Ru­(II) polypyridyl complexes have gained widespread attention as photosensitizers for photodynamic therapy (PDT). Herein, we systematically investigate a series of the type [Ru­(phen)2(IP-nT)]2+, featuring 1,10-phenanthroline (phen) coligands and imidazo­[4,5-f]­[1,10]­phenanthroline ligands tethered to n = 0–4 thiophene rings (IP-nT). The complexes were characterized and investigated for their electrochemical, spectroscopic, and (photo)­biological properties. The electrochemical oxidation of the nT unit shifted by −350 mV as n = 1 → 4 (+920 mV for Ru-1T, +570 mV for Ru-4T); nT reductions were observed in complexes Ru-3T (−2530 mV) and Ru-4T (−2300 mV). Singlet oxygen quantum yields ranged from 0.53 to 0.88, with Ru-3T and Ru-4T being equally efficient (∼0.88). Time-resolved absorption spectra of Ru-0T–1T were dominated by metal-to-ligand charge-transfer (3MLCT) states (τTA = 0.40–0.85 μs), but long-lived intraligand charge-transfer (3ILCT) states were observed in Ru-2T–4T (τTA = 25–148 μs). The 3ILCT energies of Ru-3T and Ru-4T were computed to be 1.6 and 1.4 eV, respectively. The phototherapeutic efficacy against melanoma cells (SK-MEL-28) under broad-band visible light (400–700 nm) increases as n = 0 → 4: Ru-0T was inactive up to 300 μM, Ru-1T–2T were moderately active (EC50 ∼ 600 nM, PI = 200), and Ru-3T (EC50 = 57 nM, PI &gt; 1100) and Ru-4T (EC50 = 740 pM, PI = 114,000) were the most phototoxic. The activity diminishes with longer wavelengths of light and is completely suppressed for all complexes except Ru-3T and Ru-4T in hypoxia. Ru-4T is the more potent and robust PS in 1% O2 over seven biological replicates (avg EC50 = 1.3 μM, avg PI = 985). Ru-3T exhibited hypoxic activity in five of seven replicates, underscoring the need for biological replicates in compound evaluation. Singlet oxygen sensitization is likely responsible for phototoxic effects of the compounds in normoxia, but the presence of redox-active excited states may facilitate additional photoactive pathways for complexes with three or more thienyl groups. The 3ILCT state with its extended lifetime (30–40× longer than the 3MLCT state for Ru-3T and Ru-4T) implicates its predominant role in photocytotoxicity.</description><identifier>ISSN: 0020-1669</identifier><identifier>ISSN: 1520-510X</identifier><identifier>EISSN: 1520-510X</identifier><identifier>DOI: 10.1021/acs.inorgchem.3c03216</identifier><identifier>PMID: 38079387</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><subject>Ligands ; Phenanthrolines - chemistry ; Phenanthrolines - pharmacology ; Photochemotherapy ; Photosensitizing Agents - chemistry ; Photosensitizing Agents - pharmacology ; Ruthenium - chemistry ; Ruthenium - pharmacology ; Singlet Oxygen - chemistry</subject><ispartof>Inorganic chemistry, 2023-12, Vol.62 (51), p.21181-21200</ispartof><rights>2023 American Chemical Society</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a407t-a9835a1f6d1506fc22fe883c522f64356951b8a6b264e4ad01ecf66272960ea83</citedby><cites>FETCH-LOGICAL-a407t-a9835a1f6d1506fc22fe883c522f64356951b8a6b264e4ad01ecf66272960ea83</cites><orcidid>0000-0003-0978-0894 ; 0000-0002-2922-2163 ; 0000-0001-8232-4989 ; 0009-0009-0532-8041 ; 0000-0002-8028-5055 ; 0000-0001-9925-7233</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27922,27923</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38079387$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cole, Houston D.</creatorcontrib><creatorcontrib>Vali, Abbas</creatorcontrib><creatorcontrib>Roque, John A.</creatorcontrib><creatorcontrib>Shi, Ge</creatorcontrib><creatorcontrib>Kaur, Gurleen</creatorcontrib><creatorcontrib>Hodges, Rachel O.</creatorcontrib><creatorcontrib>Francés-Monerris, Antonio</creatorcontrib><creatorcontrib>Alberto, Marta E.</creatorcontrib><creatorcontrib>Cameron, Colin G.</creatorcontrib><creatorcontrib>McFarland, Sherri A.</creatorcontrib><title>Ru(II) Phenanthroline-Based Oligothienyl Complexes as Phototherapy Agents</title><title>Inorganic chemistry</title><addtitle>Inorg. Chem</addtitle><description>Ru­(II) polypyridyl complexes have gained widespread attention as photosensitizers for photodynamic therapy (PDT). Herein, we systematically investigate a series of the type [Ru­(phen)2(IP-nT)]2+, featuring 1,10-phenanthroline (phen) coligands and imidazo­[4,5-f]­[1,10]­phenanthroline ligands tethered to n = 0–4 thiophene rings (IP-nT). The complexes were characterized and investigated for their electrochemical, spectroscopic, and (photo)­biological properties. The electrochemical oxidation of the nT unit shifted by −350 mV as n = 1 → 4 (+920 mV for Ru-1T, +570 mV for Ru-4T); nT reductions were observed in complexes Ru-3T (−2530 mV) and Ru-4T (−2300 mV). Singlet oxygen quantum yields ranged from 0.53 to 0.88, with Ru-3T and Ru-4T being equally efficient (∼0.88). Time-resolved absorption spectra of Ru-0T–1T were dominated by metal-to-ligand charge-transfer (3MLCT) states (τTA = 0.40–0.85 μs), but long-lived intraligand charge-transfer (3ILCT) states were observed in Ru-2T–4T (τTA = 25–148 μs). The 3ILCT energies of Ru-3T and Ru-4T were computed to be 1.6 and 1.4 eV, respectively. The phototherapeutic efficacy against melanoma cells (SK-MEL-28) under broad-band visible light (400–700 nm) increases as n = 0 → 4: Ru-0T was inactive up to 300 μM, Ru-1T–2T were moderately active (EC50 ∼ 600 nM, PI = 200), and Ru-3T (EC50 = 57 nM, PI &gt; 1100) and Ru-4T (EC50 = 740 pM, PI = 114,000) were the most phototoxic. The activity diminishes with longer wavelengths of light and is completely suppressed for all complexes except Ru-3T and Ru-4T in hypoxia. Ru-4T is the more potent and robust PS in 1% O2 over seven biological replicates (avg EC50 = 1.3 μM, avg PI = 985). Ru-3T exhibited hypoxic activity in five of seven replicates, underscoring the need for biological replicates in compound evaluation. Singlet oxygen sensitization is likely responsible for phototoxic effects of the compounds in normoxia, but the presence of redox-active excited states may facilitate additional photoactive pathways for complexes with three or more thienyl groups. The 3ILCT state with its extended lifetime (30–40× longer than the 3MLCT state for Ru-3T and Ru-4T) implicates its predominant role in photocytotoxicity.</description><subject>Ligands</subject><subject>Phenanthrolines - chemistry</subject><subject>Phenanthrolines - pharmacology</subject><subject>Photochemotherapy</subject><subject>Photosensitizing Agents - chemistry</subject><subject>Photosensitizing Agents - pharmacology</subject><subject>Ruthenium - chemistry</subject><subject>Ruthenium - pharmacology</subject><subject>Singlet Oxygen - chemistry</subject><issn>0020-1669</issn><issn>1520-510X</issn><issn>1520-510X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNqFkUFrGzEQhUVpqB23P6Fhj-lhnZG00q5OITFNYwgkhBZ6E7I8692wK7nSbqj_fRXsmuSU0wzM994M8wj5SmFOgdELY-O8dT5sbIP9nFvgjMoPZEoFg1xQ-P2RTAFST6VUE3Ia4xMAKF7IT2TCKygVr8opWT6O58vlt-yhQWfc0ATftQ7zaxNxnd137cYPTYtu12UL3287_IsxMzHhfkgTDGa7y6426Ib4mZzUpov45VBn5NfN95-L2_zu_sdycXWXmwLKITeq4sLQWq6pAFlbxmqsKm5FamTBhVSCriojV0wWWJg1ULS1lKxkSgKais_I5d53O656XNu0O5hOb0Pbm7DT3rT67cS1jd74Z02hFAWjKjmcHxyC_zNiHHTfRotdZxz6MWqmgCkuCmAJFXvUBh9jwPq4h4J-yUGnHPQxB33IIenOXh95VP1_fALoHnjRP_kxuPSzd0z_AQQpmVA</recordid><startdate>20231225</startdate><enddate>20231225</enddate><creator>Cole, Houston D.</creator><creator>Vali, Abbas</creator><creator>Roque, John A.</creator><creator>Shi, Ge</creator><creator>Kaur, Gurleen</creator><creator>Hodges, Rachel O.</creator><creator>Francés-Monerris, Antonio</creator><creator>Alberto, Marta E.</creator><creator>Cameron, Colin G.</creator><creator>McFarland, Sherri A.</creator><general>American Chemical Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-0978-0894</orcidid><orcidid>https://orcid.org/0000-0002-2922-2163</orcidid><orcidid>https://orcid.org/0000-0001-8232-4989</orcidid><orcidid>https://orcid.org/0009-0009-0532-8041</orcidid><orcidid>https://orcid.org/0000-0002-8028-5055</orcidid><orcidid>https://orcid.org/0000-0001-9925-7233</orcidid></search><sort><creationdate>20231225</creationdate><title>Ru(II) Phenanthroline-Based Oligothienyl Complexes as Phototherapy Agents</title><author>Cole, Houston D. ; Vali, Abbas ; Roque, John A. ; Shi, Ge ; Kaur, Gurleen ; Hodges, Rachel O. ; Francés-Monerris, Antonio ; Alberto, Marta E. ; Cameron, Colin G. ; McFarland, Sherri A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a407t-a9835a1f6d1506fc22fe883c522f64356951b8a6b264e4ad01ecf66272960ea83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Ligands</topic><topic>Phenanthrolines - chemistry</topic><topic>Phenanthrolines - pharmacology</topic><topic>Photochemotherapy</topic><topic>Photosensitizing Agents - chemistry</topic><topic>Photosensitizing Agents - pharmacology</topic><topic>Ruthenium - chemistry</topic><topic>Ruthenium - pharmacology</topic><topic>Singlet Oxygen - chemistry</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cole, Houston D.</creatorcontrib><creatorcontrib>Vali, Abbas</creatorcontrib><creatorcontrib>Roque, John A.</creatorcontrib><creatorcontrib>Shi, Ge</creatorcontrib><creatorcontrib>Kaur, Gurleen</creatorcontrib><creatorcontrib>Hodges, Rachel O.</creatorcontrib><creatorcontrib>Francés-Monerris, Antonio</creatorcontrib><creatorcontrib>Alberto, Marta E.</creatorcontrib><creatorcontrib>Cameron, Colin G.</creatorcontrib><creatorcontrib>McFarland, Sherri A.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Inorganic chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cole, Houston D.</au><au>Vali, Abbas</au><au>Roque, John A.</au><au>Shi, Ge</au><au>Kaur, Gurleen</au><au>Hodges, Rachel O.</au><au>Francés-Monerris, Antonio</au><au>Alberto, Marta E.</au><au>Cameron, Colin G.</au><au>McFarland, Sherri A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ru(II) Phenanthroline-Based Oligothienyl Complexes as Phototherapy Agents</atitle><jtitle>Inorganic chemistry</jtitle><addtitle>Inorg. Chem</addtitle><date>2023-12-25</date><risdate>2023</risdate><volume>62</volume><issue>51</issue><spage>21181</spage><epage>21200</epage><pages>21181-21200</pages><issn>0020-1669</issn><issn>1520-510X</issn><eissn>1520-510X</eissn><abstract>Ru­(II) polypyridyl complexes have gained widespread attention as photosensitizers for photodynamic therapy (PDT). Herein, we systematically investigate a series of the type [Ru­(phen)2(IP-nT)]2+, featuring 1,10-phenanthroline (phen) coligands and imidazo­[4,5-f]­[1,10]­phenanthroline ligands tethered to n = 0–4 thiophene rings (IP-nT). The complexes were characterized and investigated for their electrochemical, spectroscopic, and (photo)­biological properties. The electrochemical oxidation of the nT unit shifted by −350 mV as n = 1 → 4 (+920 mV for Ru-1T, +570 mV for Ru-4T); nT reductions were observed in complexes Ru-3T (−2530 mV) and Ru-4T (−2300 mV). Singlet oxygen quantum yields ranged from 0.53 to 0.88, with Ru-3T and Ru-4T being equally efficient (∼0.88). Time-resolved absorption spectra of Ru-0T–1T were dominated by metal-to-ligand charge-transfer (3MLCT) states (τTA = 0.40–0.85 μs), but long-lived intraligand charge-transfer (3ILCT) states were observed in Ru-2T–4T (τTA = 25–148 μs). The 3ILCT energies of Ru-3T and Ru-4T were computed to be 1.6 and 1.4 eV, respectively. The phototherapeutic efficacy against melanoma cells (SK-MEL-28) under broad-band visible light (400–700 nm) increases as n = 0 → 4: Ru-0T was inactive up to 300 μM, Ru-1T–2T were moderately active (EC50 ∼ 600 nM, PI = 200), and Ru-3T (EC50 = 57 nM, PI &gt; 1100) and Ru-4T (EC50 = 740 pM, PI = 114,000) were the most phototoxic. The activity diminishes with longer wavelengths of light and is completely suppressed for all complexes except Ru-3T and Ru-4T in hypoxia. Ru-4T is the more potent and robust PS in 1% O2 over seven biological replicates (avg EC50 = 1.3 μM, avg PI = 985). Ru-3T exhibited hypoxic activity in five of seven replicates, underscoring the need for biological replicates in compound evaluation. Singlet oxygen sensitization is likely responsible for phototoxic effects of the compounds in normoxia, but the presence of redox-active excited states may facilitate additional photoactive pathways for complexes with three or more thienyl groups. The 3ILCT state with its extended lifetime (30–40× longer than the 3MLCT state for Ru-3T and Ru-4T) implicates its predominant role in photocytotoxicity.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>38079387</pmid><doi>10.1021/acs.inorgchem.3c03216</doi><tpages>20</tpages><orcidid>https://orcid.org/0000-0003-0978-0894</orcidid><orcidid>https://orcid.org/0000-0002-2922-2163</orcidid><orcidid>https://orcid.org/0000-0001-8232-4989</orcidid><orcidid>https://orcid.org/0009-0009-0532-8041</orcidid><orcidid>https://orcid.org/0000-0002-8028-5055</orcidid><orcidid>https://orcid.org/0000-0001-9925-7233</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0020-1669
ispartof Inorganic chemistry, 2023-12, Vol.62 (51), p.21181-21200
issn 0020-1669
1520-510X
1520-510X
language eng
recordid cdi_proquest_miscellaneous_2902935402
source American Chemical Society:Jisc Collections:American Chemical Society Read & Publish Agreement 2022-2024 (Reading list)
subjects Ligands
Phenanthrolines - chemistry
Phenanthrolines - pharmacology
Photochemotherapy
Photosensitizing Agents - chemistry
Photosensitizing Agents - pharmacology
Ruthenium - chemistry
Ruthenium - pharmacology
Singlet Oxygen - chemistry
title Ru(II) Phenanthroline-Based Oligothienyl Complexes as Phototherapy Agents
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T07%3A47%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ru(II)%20Phenanthroline-Based%20Oligothienyl%20Complexes%20as%20Phototherapy%20Agents&rft.jtitle=Inorganic%20chemistry&rft.au=Cole,%20Houston%20D.&rft.date=2023-12-25&rft.volume=62&rft.issue=51&rft.spage=21181&rft.epage=21200&rft.pages=21181-21200&rft.issn=0020-1669&rft.eissn=1520-510X&rft_id=info:doi/10.1021/acs.inorgchem.3c03216&rft_dat=%3Cproquest_pubme%3E2902935402%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-a407t-a9835a1f6d1506fc22fe883c522f64356951b8a6b264e4ad01ecf66272960ea83%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2902935402&rft_id=info:pmid/38079387&rfr_iscdi=true